C2969-.2ML Display Image

Monoclonal Anti-I-CAM-1 (CD54) antibody produced in mouse, clone 8.4A6, purified immunoglobulin, 2 mg/mL

Code: C2969-.2ML D2-231

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to b...


read more

Your Price
£408.00 EACH

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

TNF-α activated human endothelial cells.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4.

Preparation Note

Product filtered through a 0.2 µm filter

Specificity

The antibody recognizes the human CD54 (I-CAM-1) surface antigen by flow cytometry, ELISA, immunocytochemistry, and immunohistochemistry. It inhibits human leukocyte adhesion to activated endothelial cells and stimulates homotypic aggregation of SKW3 cells. The epitope recognized by the antibody is localized in domain D2 of the CD54 molecule.5th Workshop: code no. S 100

Target description

CD54 (I-CAM-1) is a glycoprotein involved in mediation of intercellular adhesion. CD54 is expressed by activated endothelial cells and is also detected on cells of many other lineages and in plasma.

antibody formpurified immunoglobulin
antibody product typeprimary antibodies
biological sourcemouse
clone8.4A6, monoclonal
conjugateunconjugated
Gene Informationhuman ... ICAM1(3383)
isotypeIgG1
mol wtantigen 85-110 kDa
shipped inwet ice
species reactivityhuman, monkey
storage temp.−20°C
technique(s)indirect ELISA: suitable, immunocytochemistry: suitable, flow cytometry: suitable, immunohistochemistry (frozen sections): suitable
UniProt accession no.P05362
This product has met the following criteria: